Galectin Therapeutics Inc. · NASDAQ:GALT
Galectin Therapeutics Inc. shareholders
As of Jun 30, 2026, 95 institutions reported holding Galectin Therapeutics Inc., 15.6% of its shares. Largest: BlackRock, Vanguard and Geode Capital. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Galectin Therapeutics Inc. | Change | Filed |
|---|---|---|---|---|
| BlackRock | 2.99M | 3.0% | +2.19M | Aug 7, 2026 |
| Vanguard | 2.88M | 2.9% | +592K | Aug 13, 2026 |
| Geode Capital | 1.31M | 1.3% | +696K | Aug 12, 2026 |
| Osaic Holdings, Inc. | 1.2M | 1.2% | +81,055 | Aug 14, 2026 |
| Marshall Wace, LLP | 831K | 0.82% | −389K | Aug 13, 2026 |
| Wealthspire Advisors, LLC | 722K | 0.72% | no change | Aug 11, 2026 |
| State Street | 568K | 0.56% | +309K | Aug 7, 2026 |
| Commonwealth Equity Services, LLC | 407K | 0.40% | +40,000 | Jul 29, 2026 |
| Northern Trust | 387K | 0.38% | +256K | Aug 13, 2026 |
| Two Sigma | 318K | 0.32% | −149K | Aug 14, 2026 |